Mira Pharmaceuticals WKN: A3EQWL ISIN: US60458C1045 Kürzel: MIRA

⬆️

🔣

🌻

@everyone WL for PM AIMD .60-.65 PB w sl under .55 or .75 breakout. Levels .56/.60/.65/.75/.84/.94/1 LGMK .27-.30 PB w sl under .25 or AH highs breakout. Levels .21/.25/.27/.30/.36/.40/.45/.53/.60 MIRA 2.10 PB w sl under 2 or 2.35 breakout Levels 2/2.10/2.25/2.35/2.50/2.60/2.75/3

$MIRA Preclinical Success with Ketamir-2: Drug Candidate: MIRA Pharmaceuticals provided an update on its drug candidate, Ketamir-2, focusing on its principal metabolite, Nor-Ketamir-2. New Findings: The company unveiled promising preclinical data indicating that Nor-Ketamir-2 is a longer-acting, brain-penetrating, and selective compound. It interacts specifically with the NMDA Complex's PCP receptor while avoiding activity on the glutamate NMDA site, which could potentially offer a more targeted therapeutic approach. Enhanced Formulation: A new salt formulation of Ketamir-2, called Ketamir-2 Pamoate, has been developed to improve its pharmacokinetics. This formulation has shown nearly 100% oral bioavailability and improved brain penetration. Regulatory Progress: MIRA Pharmaceuticals is actively working on Investigational New Drug (IND)-enabling studies and scaling up the drug under Good Manufacturing Practice (GMP) standards. The company plans to submit an IND application by the end of 2024, aiming to begin clinical trials shortly after.

🌻

🥃

Immer im Auge behalten….. The company has 6.3 months of cash left based on quarterly cash burn of -$1.05M and estimated current cash of $2.2M.

4 -5 ….

Wieviel Halts bis jetzt? 🙈

📸

Krass

Jetzt konnte jeder sehen wie man manipulieren kann , schon bei koss war krass , heute bei Mira 🤦‍♀️

🥃🥃🥃

jetzt bin ich sprachlos